Nodular toxic goiter in children: clinical features, morphological variants

BACKGROUND: Toxic nodular goiter (TNG) is a rare disease in which the cause of hyperthyroidism is the presence of a node or nodes that autonomously secrete thyroid hormones. With children and adolescents this condition is extremely rare — in 5–7.5% of all cases of nodular goiter. Therapy of toxic nodular goiter is aimed at relieving the symptoms of hyperthyroidism taking into account the malignant potential of the nodular formation. In the available literature, there are no data on the clinical course, comparative results of cytological and histological data in patients with toxic nodular goiter, which debuted in their childhood.
AIM: Analysis of the features of the clinical course, comparison of the results of cytological and histological studies of toxic nodular goiter in children and adolescents.
MATERIALS AND METHODS: A retrospective, single-center study of 21 patients with single-nodular toxic goiter, hospitalized at the Endocrinology Research Centre in the period from January 2016 to December 2019.
RESULTS: The mean age at the time of the survey was 13.9 years. Thirteen patients (65%) had manifest thyrotoxicosis, and seven (35%) had subclinical hyperthyroidism. More than half of children — 57.1% (n = 12) did not receive thyreostatic therapy. The cytological picture in 11 patients (61.1%) corresponded to benign changes (nodular colloid goiter or adenomatous goiter) — Bethesda II, in 4 patients — follicular tumor — Bethesda IV, in 4 children the study was not informative. 19 patients (90.5%) underwent surgical treatment (hemithyroidectomy). According to the results of histological examination, follicular adenoma was found in 44.4% of children with nodular toxic goiter with benign results of TAB (Bethesda II) and was found in 50% with revealing follicular neoplasia (Bethesda IV).
CONCLUSION: For the first time in the Russian Federation was carried out a comparative analysis of the characteristics of cytological and histological studies in children with toxic nodular goiter. It is significant that only in 10.5% (n=2) cytological and morphological results were consistent. The choice of radical treatment tactics should take into account the high frequency of mismatches between histological and morphological studies.

1. Egorycheva EK. Retseptor tireotropnogo gormona gipofiza pri funktsional’noi avtonomii shchitovidnoi zhelezy. [dissertation]. Moscow; 2007. (In Russ.)

2. Miller JM. Plummer’s Disease. Med Clin North Am. 1975;59(5):1203-1216. doi: https://doi.org/10.1016/S0025-7125(16)31968-X

3. Hodax JK, Reinert SE, Quintos JB. Autonomously functioning thyroid nodules in patients <21 years of age: the rhode island hospital experience from 2003-2013. Endocrine Practice. 2016;22(3):328-337. doi: https://doi.org/10.4158/EP15905.OR

4. Aghini-Lombardi F. The Spectrum of Thyroid Disorders in an Iodine-Deficient Community: The Pescopagano Survey. J Clin Endocrinol Metab. 1999;84(2):561-566. doi: https://doi.org/10.1210/jc.84.2.561

5. Goldstein R, Hart IR. Follow-up of Solitary Autonomous Thyroid Nodules Treated with 131I. N Engl J Med. 1983;309(24):1473-1476. doi: https://doi.org/10.1056/NEJM198312153092401

6. Wondisford F, Radovick S. Clinical Management of Thyroid Disease. Saunders; 2009. 440 p.

7. Wong CKM, Wheeler MH. Thyroid Nodules: Rational Management. World J Surg. 2000;24(8):934-941. doi: https://doi.org/10.1007/s002680010175

8. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am. 1997;26(4):777-800. doi: https://doi.org/10.1016/S0889-8529(05)70282-6

9. Erdoğan MF, Anil C, Özer D, et al. Is it useful to routinely biopsy hot nodules in iodine deficient areas? J Endocrinol Invest. 2003;26(2):128-131. doi: https://doi.org/10.1007/BF03345140

10. Falk SA. Surgical treatment of hyperthyroidism / In: Falk SA, editor. Thyroid disease. New York: Lippincott-Raven; 1997. P. 319-340.

11. Alferova VI, Mustafina SV, Rymar OD. Iodine status of the population in Russia and the world: what do we have for 2019? Clin Exp Thyroidol. 2019;15(2):73-82. (In Russ.) doi: https://doi.org/10.14341/ket10353

12. Troshina EA, Platonova NM, Abdulkhabirova FM, Gerasimov GA. Iododefitsitnye zabolevaniya v Rossiiskoi Federatsii: vremya prinyatiya reshenii. Dedov II, Mel’nichenko GA, editors. Moscow; 2012. (In Russ.)

13. Iododefitsitnye zabolevaniya u detei i podrostov: diagnostika, lechenie, profilaktika. Nauchnoprakticheskaya programma. Moscow: Mezhdunarodnyi fond okhrany zdorov'ya materi i rebеnka. 2005. 48 p. (In Russ.)

14. Russ G, Bonnema SJ, Erdogan MF, et al. The Bethesda System for Reporting Thyroid Cytopathology. Boston, MA: Springer US; 2010. doi: https://doi.org/10.1007/978-0-387-87666-5

15. Niedziela M, Breborowicz D, Trejster E, Korman E. Hot Nodules in Children and Adolescents in Western Poland from 1996 to 2000: Clinical Analysis of 31 Patients. J Pediatr Endocrinol Metab. 2002;15(6). doi: https://doi.org/10.1515/JPEM.2002.15.6.823

16. Dedov II, Mel’nichenko GA. Endokrinologiya. Natsional’noe rukovodstvo. 2021. P. 616-624 (In Russ.)

17. Nygaard B, Faber J, Veje A, et al. Transition of Nodular Toxic Goiter to Autoimmune Hyperthyroidism Triggered by 131I Therapy. Thyroid. 1999;9(5):477-481. doi: https://doi.org/10.1089/thy.1999.9.477

18. Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36(6):425-437. doi: https://doi.org/10.1002/dc.20830

19. Smith M, Pantanowitz L, Khalbuss WE, et al. Indeterminate Pediatric Thyroid Fine Needle Aspirations: A Study of 68 Cases. Acta Cytol. 2013;57(4):341-348. doi: https://doi.org/10.1159/000351029

20. Monaco SE, Pantanowitz L, Khalbuss WE, et al. Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration. Cancer Cytopathol. 2012. doi: https://doi.org/10.1002/cncy.21199

21. Smith JJ, Chen X, Schneider DF, et al. Toxic Nodular Goiter and Cancer: A Compelling Case for Thyroidectomy. Ann Surg Oncol. 2013;20(4):1336-1340. doi: https://doi.org/10.1245/s10434-012-2725-4

22. Giles (Senyurek) Y, Fatih T, Harika B, et al. The risk factors for malignancy in surgically treated patients for Graves’ disease, toxic multinodular goiter, and toxic adenoma. Surgery. 2008;144(6):1028-1037. doi: https://doi.org/10.1016/j.surg.2008.08.022

23. Thomas CG, Croom RD. Current Management of the Patient with Autonomously Functioning Nodular Goiter. Surg Clin North Am. 1987;67(2):315-328. doi: https://doi.org/10.1016/S0039-6109(16)44186-1